Rigel Pharmaceuticals' Unattributed VC - III Round

Rigel Pharmaceuticals raised a round of funding on June 05, 2003.

Rigel Pharmaceuticals discovers and develops drugs for the treatment of inflammatory/ autoimmune diseases and cancer, as well as viral and metabolic diseases. Their research focuses on intracellular s…

Articles about Rigel Pharmaceuticals' Unattributed VC - III Round: